Next Article in Journal
Immunogenicity of Intradermal Versus Intramuscular BNT162b2 COVID-19 Booster Vaccine in Patients with Immune-Mediated Dermatologic Diseases: A Non-Inferiority Randomized Controlled Trial
Next Article in Special Issue
Humoral Response and Safety after a Fourth Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer Patients Undergoing Active Treatment—Results of a Prospective Observational Study
Previous Article in Journal
DNA Vaccines: Their Formulations, Engineering and Delivery
Previous Article in Special Issue
Tip Lesion Most Frequent FSGS Variant Related to COVID-19 Vaccine: Two Case Reports and Literature Review
 
 
Article

Article Versions Notes

Action Date Notes Link
article xml file uploaded 11 January 2024 11:16 CET Original file -
article xml uploaded. 11 January 2024 11:16 CET Update https://www.mdpi.com/2076-393X/12/1/72/xml
article pdf uploaded. 11 January 2024 11:16 CET Version of Record https://www.mdpi.com/2076-393X/12/1/72/pdf
article supplementary file uploaded. 11 January 2024 11:16 CET - https://www.mdpi.com/2076-393X/12/1/72#supplementary
article html file updated 11 January 2024 11:17 CET Original file -
article html file updated 12 January 2024 10:34 CET Update -
article html file updated 12 January 2024 10:35 CET Update https://www.mdpi.com/2076-393X/12/1/72/html
Back to TopTop